ZIAUDDIN UNIVERSITY

Lack of local data on diseases in Pakistan hinders healthcare advancement; experts call for more in-country clinical trials and public participation. Workshops emphasize the need for robust databases and adherence to global standards like GCP guidelines to develop targeted therapies. Universities like ZU and UMDC commit to international trials, aiming to improve local treatment options and establish Pakistan as a key player in clinical research.